ClinicalTrials.Veeva

Menu

Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia

A

Ain Shams University

Status

Completed

Conditions

Ventilator Associated Pneumonia

Treatments

Diagnostic Test: Lung Ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT04563104
R 49 / 2020

Details and patient eligibility

About

Ventilator Associated pneumonia (VAP) is associated with longer ICU length of stay, prolonged mechanical ventilation, and increased use of antimicrobials, health-care cost and mortality . Acute respiratory infections (ARIs) comprise a large and heterogeneous group of infections, including bacterial infections, viral infections, and infections of other etiologies. Early initiation of adequate antibiotic therapy is the cornerstone in the treatment. However, overuse of antibiotics and prolonged duration of antibiotic therapy in patients with bacterial ARIs in the hospital and intensive care setting is associated with increased resistance for common bacteria, high costs, and adverse drug reactions.

Enrollment

62 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years old or greater
  • Ventilator associated pneumonia (VAP) with positive sputum culture.

Exclusion criteria

  • pregnancy,
  • use of immunosuppressive agents except for steroids,
  • neutropenia (white blood cell count ≤1000/mL)
  • patients whose primary diagnosis was community acquired pneumonia and other source of infection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems